Cargando…
Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations
Malignant Mesothelioma is an uncommon and very aggressive tumor that accounts for 1% of all the deaths secondary to malignancy in humans. Interestingly, this neoplasm has been occasionally described in companion animals as well. Aim of this study was the preclinical evaluation of the combination of...
Autores principales: | Spugnini, Enrico P, Crispi, Stefania, Scarabello, Alessandra, Caruso, Giovanni, Citro, Gennaro, Baldi, Alfonso |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438333/ https://www.ncbi.nlm.nih.gov/pubmed/18577247 http://dx.doi.org/10.1186/1756-9966-27-6 |
Ejemplares similares
-
Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma
por: Baldi, Alfonso, et al.
Publicado: (2011) -
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2008) -
Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans
por: Spugnini, Enrico P, et al.
Publicado: (2009) -
Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2022) -
Patterns of tumor response in canine and feline cancer patients treated with electrochemotherapy: preclinical data for the standardization of this treatment in pets and humans
por: Spugnini, Enrico P, et al.
Publicado: (2007)